AbbVie Inc. (NYSE:ABBV) dropped -0.13% and closed the trade at $ 63.27. The company recorded a trading capacity of 11.17 million shares above its three months average daily volume of 7.28 million shares. During the last trade, shares reached to high price of $63.79 and touched the low price of $63.17. The stock’s 50-day moving average is noted at $65.56 and its 200-day moving average is stands at $61.66.
Additionally, the company has a PE ratio of 18.25 and has EPS of 3.47. The company has market capitalization of $103.04B.
Currently AbbVie Inc. (ABBV) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “11″ Analysts”. “1” rated “Sell” for the company. “9” said the company as a “Hold”. Overweight rating was given by “1” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $71.46 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $90.00 however minimum price target advised by analysts is $49.00. The Median price target for the stock is measured at $71.50.
Presently, Analysts decided consensus EPS estimate of $1.20 for present quarter and one month ago projected EPS estimate was at $1.20. If we take a look at back 3 month ago, consensus EPS estimate was $1.20.
A current consensus EPS estimate for next quarter is at $1.19 and 3 month ago EPS forecast was $1.21. Have a look at back 1 month ago, consensus EPS forecast was seen at $1.20.
For current fiscal year, most recent EPS estimate is set at $4.80 based on Analyst consensus and three month ago consensus EPS opinions was at $4.76. During period one month ago, consensus EPS forecast was decided at $4.80.
A current consensus EPS projection for next fiscal year is observed at $5.65 and one month ago consensus EPS forecast was at $5.67. Take a look at back three month ago, consensus EPS estimate opinions was decided at $5.61 by analysts.
One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 12 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 8 advised the “Hold” rating about this stock. 1 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 12 said a “Buy Rating” and 0 announced “Overweight Rating”. 8 advised “Hold Rating” regarding the stock. 1 announced “Sell Rating” and 0 disclosed “Underweight Rating”.